InsiderClue
Insiders · Profile

Novartis Institutes for BioMedical Research, Inc.

10% owner at Intellia Therapeutics. Filing since 11 May 2016. CIK 0001673852

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
12 Dec 2017
10% owner
Sold, plan not stated
1,523,000
$27.87M
26.9%
NTLA Intellia Therapeutics, Inc.
11 May 2016
10% owner
Bought
277,777
$5.00M
5.2%
2 decisions on file.